PROSPECTS AND OPPORTUNITIES
Analgesics set for steady growth driven by household stockpiling
Retail sales of analgesics in Lithuania are expected to rise in constant value terms (at 2025 prices) over the forecast period. Following the severity of the 2024–2025 cold and flu season, households are likely to maintain higher levels of ibuprofen and acetaminophen “on standby” for both adults and children, especially during autumn–winter peaks.
Rise of fast-acting formats
On the product side, fast-acting technologies in ibuprofen and acetaminophen - such as salt formulations, soft capsules and rapid-disintegration tablets - are expected to feature more prominently in brand portfolios. These formats are positioned as offering faster relief, without altering the active ingredients, and taken together, will keep value growth ahead of pure volume gains.
Digital information and sustainability will shape analgesic packaging
Environmental responsibility and digital innovation are increasingly influencing how analgesics are packaged in Lithuania. EU regulators have formalised electronic product information (ePI) standards, enabling QR-code access to up-to-date leaflets.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Lithuania with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Lithuania, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Lithuania report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Lithuania?
- Which are the leading brands in Analgesics in Lithuania?
- How are products distributed in Analgesics in Lithuania?
- How has the regulatory and operating environment for Analgesics changed in Lithuania?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Lithuania - Category analysis
KEY DATA FINDINGS
Growth sustained by flu-driven demand
US Pharmacia leads, while Nycomed gains momentum
Pharmacies stay dominant, but digital channels surge in popularity
Analgesics set for steady growth driven by household stockpiling
Rise of fast-acting formats
Digital information and sustainability will shape analgesic packaging
Consumer Health in Lithuania - Industry Overview
Consumer health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!